IKENA ONCOLOGY INC's ticker is IKNA and the CUSIP is 45175G108. A total of 59 filers reported holding IKENA ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,443,445 | -32.2% | 2,180,934 | +2.8% | 3.74% | -11.4% |
| Q2 2023 | $13,920,582 | +142.9% | 2,122,040 | +27.8% | 4.22% | +177.7% |
| Q1 2023 | $5,730,010 | +31.6% | 1,660,872 | +1.4% | 1.52% | +31.1% |
| Q4 2022 | $4,355,409 | +1.0% | 1,637,372 | +34.8% | 1.16% | +0.1% |
| Q3 2022 | $4,311,000 | -10.8% | 1,214,304 | +11.3% | 1.16% | -37.2% |
| Q2 2022 | $4,833,000 | -2.8% | 1,090,937 | +33.9% | 1.85% | -12.6% |
| Q1 2022 | $4,970,000 | -51.4% | 814,755 | -0.0% | 2.11% | -37.7% |
| Q4 2021 | $10,217,000 | +157.0% | 814,756 | +158.7% | 3.39% | +192.3% |
| Q3 2021 | $3,975,000 | -65.3% | 315,000 | -61.3% | 1.16% | -56.4% |
| Q2 2021 | $11,440,000 | -50.3% | 814,756 | 0.0% | 2.66% | -42.3% |
| Q1 2021 | $23,017,000 | – | 814,756 | – | 4.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,249,123 | $63,538,000 | 6.01% |
| CHI Advisors LLC | 814,756 | $23,017,000 | 4.61% |
| Octagon Capital Advisors LP | 400,000 | $11,300,000 | 4.26% |
| BVF INC/IL | 1,599,658 | $45,190,000 | 1.69% |
| Logos Global Management LP | 419,853 | $11,861,000 | 1.16% |
| Orbimed Advisors | 2,933,941 | $82,884,000 | 0.78% |
| Artal Group S.A. | 1,549,513 | $43,774,000 | 0.77% |
| HealthCor Management, L.P. | 341,212 | $9,639,000 | 0.34% |
| RA Capital Management | 750,000 | $21,188,000 | 0.32% |
| Nantahala Capital Management | 325,000 | $9,181,000 | 0.27% |